Human Vaccines & Immunotherapeutics

Papers
(The H4-Index of Human Vaccines & Immunotherapeutics is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Human vaccines & immunotherapeutics: News October 2022175
Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China121
Human vaccines and immunotherapeutics: News December 2023120
Comment on the “Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao’an district of She110
Do Pentavalent (DTwP-Hib-HBV) vaccines have sex-differential nonspecific effects? An observational study106
Healthcare workers’ and caregivers’ knowledge, perceptions and experiences of the school-based human papillomavirus (HPV) immunization program: A qualitative study in eThekwini District of the KwaZulu84
Determinants of basic childhood vaccination coverage in European and OECD countries82
Enhancing COVID-19 booster vaccination among the elderly through text message reminders80
Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control73
Drivers and barriers to influenza vaccination in the post–COVID-19 era in the Federation of Bosnia and Herzegovina: A qualitative study using focus groups with risk groups and in-depth interviews with69
The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance68
Beliefs and barriers of COVID-19 vaccination hesitancy among Sudanese healthcare workers in Sudan: A cross sectional study68
Booster vaccines dose reduced mortality in hospitalized COVID-19 patients requiring oxygen supplementation: Evidence from the Beijing Omicron outbreak68
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children67
Childhood vaccination uptake among children born in Aotearoa New Zealand based on parental nationality66
The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain65
Impact of propensity to COVID-19 vaccination/vaccine on influenza vaccination from willingness to behavior among older adults in rural China64
Implementing interventions to start HPV vaccination at age 9: Using the evidence we have63
Uptake, adverse effect, and associated factors of COVID-19 vaccine among those living with human immunodeficiency virus, at Bole sub-city health facility Addis Ababa, Ethiopia59
Depemokimab: A twice yearly anti–IL 5 biologic for chronic rhinosinusitis with nasal polyps (CRSwNP) – A narrative review57
Assessment of COVID-19 vaccine take-up and its predictors among healthcare professionals in public hospitals, Addis Ababa, Ethiopia: Facility-based cross-sectional study57
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies56
HPV vaccination scenario and parental willingness to pay among girls aged 9–14 y in the Yangtze River Delta, China52
Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam49
Community based participatory research as a promising practice for addressing vaccine hesitancy, rebuilding trust and addressing health disparities among racial and ethnic minority communities49
Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer48
A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector48
A novel anti-PcrV monoclonal antibody inhibits toxin-mediated cytotoxicity and enhances survival in mouse models of Pseudomonas aeruginosa infection46
Visual analysis of the research frontiers, hotspots and development trends of immunization programs for women and children46
Acceptability of patient-centered digital vaccine safety monitoring: A Canadian Immunization Research Network study44
Single-cell analysis unravels the role of NK cells and monocytes in the control of SARS-CoV-2 breakthrough infections in vaccinated individuals42
Age- and time-dependent waning vaccine effectiveness of PPV23 against community-acquired pneumonia among adults aged 60 and older: A cohort study42
Characterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean: A review of the literature41
The effect of preexisting antibodies from Tdap vaccination during pregnancy on infant antibody responses to the pertussis-containing vaccines40
Associations between vaccination clinic factors and DTaP dropout in China: A cross-sectional study40
Immune response to and virological profile of SARS-CoV-2 before and after symptom onset in individuals vaccinated with inactivated COVID-19 vaccines40
Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention38
A cross-sectional study assessing Pro-VC-Be short-form questionnaire in Canada; measuring psychosocial determinants of vaccination behavior in Canadian healthcare professionals38
Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children38
A Bayesian re-analysis of the DANFLU-1 trial38
0.1420910358429